Atopic Dermatitis
📧 Sign up to get email alerts when something new happens for Atopic Dermatitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-05-14Clinical Trial Update: Study to Assess the Effect of "Eucerin AtopiControl" on Dermal Symptoms in Patients With Atopic Dermatitis [NA]
A completed clinical trial evaluating the effect of Eucerin AtopiControl on dermal symptoms in patients with atopic dermatitis (and pollen a…
-
CLINICAL_TRIALS research · 2018-05-11Clinical Trial Update: Open-Label Study of RVT-501 Topical Ointment in Pediatric Patients With Atopic Dermatitis [Phase 1]
Open-label Phase 1 study evaluating RVT-501 topical ointment in pediatric patients with atopic dermatitis; the document provides trial detai…
-
FDA approval · 2018-05-10FDA Approved: CLOBETASOL PROPIONATE — Original Application (Glenmark Pharmaceutcials Inc., USA)
FDA approved the Original Application for clobetasol propionate topical (generic) by Glenmark Pharmaceuticals Inc., USA.
-
CLINICAL_TRIALS trial_result · 2018-05-08Clinical Trial Update: A Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of 2 Doses of S-777469 in Patients With Atopic Dermatitis [Phase 2]
This clinical trial update reports the completion of a Phase 2 randomized, double-blind study evaluating two doses of S-777469 for atopic de…
-
CLINICAL_TRIALS trial_result · 2018-05-01Clinical Trial Update: A Phase Ib/IIa, Double-Blind, Randomized Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of S-777469 in Subjects With Atopic Dermatitis [Phase 1, Phase 2]
Phase Ib/IIa, double-blind, randomized study evaluating the safety, tolerability, pharmacokinetics, and pharmacodynamics of S-777469 in subj…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2018-04-23FDA Approved: FLUOCINONIDE — Original Application (NorthStar RxLLC)
FDA approved Fluocinonide through an Original Application (generic) submitted by NorthStar RxLLC.
-
CLINICAL_TRIALS trial_result · 2018-04-18Clinical Trial Update: DMT210 Topical Gel in the Treatment of Atopic Dermatitis [Phase 2]
A Phase 2 clinical trial of DMT210 topical gel for atopic dermatitis has completed.
-
CLINICAL_TRIALS trial_result · 2018-04-18Clinical Trial Update: Open Label Study of Long Term Treatment of Pediatric Treatment of Atopic Dermatitis With Pimecrolimus Cream 1% Within a Usual Clinical Setting [Phase 4]
This Phase 4 open-label study evaluated the long-term safety and tolerability of pimecrolimus cream 1% in pediatric patients with atopic der…
-
FDA approval · 2018-04-17FDA Approved: CLOBETASOL PROPIONATE — Original Application (Xiromed, LLC)
FDA approved the original application for clobetasol propionate (topical) by Xiromed, LLC. It is a potent corticosteroid indicated for corti…
-
CLINICAL_TRIALS trial_result · 2018-04-17Clinical Trial Update: Topical Solution for the Treatment of Atopic Dermatitis [Phase 2]
A Phase 2 topical solution for atopic dermatitis has completed its clinical trial. The sponsor is Spherium Biomed.
-
CLINICAL_TRIALS trial_result · 2018-04-17Clinical Trial Update: Antipruritic Effect of Acupuncture in Patients With Atopic Dermatitis [NA]
A completed clinical trial evaluated the antipruritic effect of acupuncture in patients with Atopic dermatitis.
-
CLINICAL_TRIALS trial_result · 2018-04-02Clinical Trial Update: Soothing and Barrier Restoration Activity of a Body Cream for Atopic Skin [NA]
Completed clinical trial evaluating a body cream's soothing and barrier-restoring activity for atopic dermatitis.
-
CLINICAL_TRIALS research · 2018-04-02Clinical Trial Update: Revitalization of Damaged Skin Due to Chronic Skin Diseases [EARLY_Phase 1]
A Phase 1 clinical trial update from Ace Cells Lab Limited evaluating a therapy to revitalize damaged skin in chronic dermatitis conditions,…
-
FDA approval · 2018-03-28FDA Approved: DIPROLENE — Supplemental Application (Organon LLC)
FDA approved a supplemental application for Diprolene (betamethasone dipropionate) from Organon LLC.
-
CLINICAL_TRIALS trial_result · 2018-03-27Clinical Trial Update: A Phase 1 Study of KHK4083 in Subjects With Atopic Dermatitis [Phase 1]
A Phase 1 study of KHK4083 in atopic dermatitis has completed. The update provides the status but does not include trial results.
-
FDA approval · 2018-03-26FDA Approved: CLOBETASOL PROPIONATE — Original Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved a generic clobetasol propionate topical product from Glenmark Pharmaceuticals (ANDA 209004) for treatment of inflammatory and p…
-
CLINICAL_TRIALS trial_result · 2018-03-22Clinical Trial Update: Inhibitory Receptors in Eosinophils of Atopic Subjects
This completed clinical trial examined inhibitory receptors on eosinophils from atopic subjects to understand immunoregulation in allergic d…
-
CLINICAL_TRIALS research · 2018-03-22Clinical Trial Update: Serotonin Levels in Atopic Dermatitis Patients
This clinical trial update reports on serotonin level measurements in patients with atopic dermatitis, sponsored by Assiut University.
-
CLINICAL_TRIALS trial_result · 2018-03-20Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of ATx201 in Subjects With Moderate Atopic Dermatitis [Phase 2]
UNION Therapeutics completed a Phase 2 trial evaluating the safety and efficacy of ATx201 in adults with moderate atopic dermatitis.
-
FDA approval · 2018-03-16FDA Approved: DESOXIMETASONE — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' desoximetasone topical product under an original application, enabling a generic version of this topical…
-
CLINICAL_TRIALS trial_result · 2018-03-15Clinical Trial Update: The Effectiveness of Tailored Messages on the Usage of Emollient in Patients With Atopic Dermatitis [NA]
A completed clinical trial evaluating whether tailored messages improve emollient usage in patients with atopic dermatitis.
-
CLINICAL_TRIALS trial_result · 2018-03-14Clinical Trial Update: A Study of Baricitinib (LY3009104) in Participants With Moderate-to-Severe Atopic Dermatitis [Phase 2]
Phase 2 trial update for baricitinib in moderate-to-severe atopic dermatitis completed with results posted in 2018.
-
CLINICAL_TRIALS research · 2018-03-13Clinical Trial Update: Study of Autologous Total Immunoglobulin G Therapy for Atopic Dermatitis [Phase 2, Phase 3]
The document notes completion of a Phase 2/Phase 3 clinical study evaluating autologous total immunoglobulin G therapy for atopic dermatitis…
-
CLINICAL_TRIALS research · 2018-03-12Clinical Trial Update: Efficacy of Topical Coal Tar in Children With Atopic Dermatitis [Phase 4]
Phase 4 clinical trial evaluating the efficacy of topical coal tar in children with atopic dermatitis. The current status of the trial is un…
-
CLINICAL_TRIALS trial_result · 2018-03-08Clinical Trial Update: Long-term Observational Study to Evalution the Safety and Efficacy of FURESTEM-AD Inj.
This clinical trial update describes a long-term observational study assessing the safety and efficacy of FURESTEM-AD Inj. in people with at…